Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Microfluidics-enabled fluorinated assembly of EGCG-ligands-siTOX nanoparticles for synergetic tumor cells and exhausted t cells regulation in cancer immunotherapy

Fig. 2

Preparation and characterization of LFNPs and LFNPs/siRNA complexes. The characterization of LFNPs1 A, LFNPs2 B, and LFNPs3 C determined by TEM, particle size (PDI), and zeta potential (n = 3). D The size distribution of different complexes prepared by microfluidic and manual mixing (n = 3)

Back to article page